SUTTER ROCK CAPITAL CORP SSSS 深 滬
已收盤 06-30 16:00:00 美东时间
12.54
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 12.54
- 總市值 3.27亿
- 52周最高 14.9799
- 市盈率 靜 7.40
- 換手率 0.00%
- 52周最低 7.6606
- 委 比 0.00%
- 總股本 2607.02万
- 歷史最高 14.9799
- 量 比 0
- 振 幅 0.00%
- 歷史最低 -5.88
- 每 手 1
- 風險率 1.87%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Neostellar Capital Corp. to Report Second Quarter 2026 Financial Results on Wednesday, August 5, 2026
Neostellar Capital Corp. (Nasdaq: NSLR), formerly SuRo Capital Corp., announced it will report its Q2 2026 financial results after U.S. market close on August 5, 2026. A conference call and webcast for investors will be held at 2:00 p.m. PT (5:00 p.m. ET) on the same day. U.S. participants can dial 833-492-0058, while international participants can dial +1 973-528-0128, both using conference ID 565747. A live webcast will also be available on the...
07-29 20:05
Neostellar Capital Corp. Announces Second Quarter 2026 Preliminary Investment Portfolio Update
Neostellar Capital Corp. provided a preliminary update on its investment portfolio for the second quarter ended June 30, 2026. The company completed its $15 million investment in TensorWave via Magnetar Opportunity 2025-4 LP, bringing its total investment to $20 million. Additionally, it invested $9.5 million in ClickHouse. The preliminary net asset value per share is estimated to be between $13.25 and $13.75. The company also exited certain inve...
07-08 20:05
美股收盘：美伊和平协议预期持续升温！三大指数周均累涨约0.7%；SpaceX上市首日涨19%，总市值2.1万亿美元
美伊和平协议预期持续升温！三大指数周均累涨约0.7%；SpaceX上市首日涨19%，总市值2.1万亿美元；太空概念股大跌，维珍银河跌超31%；存储概念股走强，闪迪涨超5%>>
06-13 09:07
Graham, Appian And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures rise, Nasdaq up 1%. Graham Corp shares down 8.7%. Other stocks declining in pre-market trading: BVC, TLK, INDP, APPN, WIX, KB, SSSS, IPSC, AMPL, ICCM, SBSW, ROMA.
06-08 20:04
美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
Barrington Research Maintains Outperform on SuRo Capital, Raises Price Target to $18
Barrington Research analyst Alexander Paris maintains SuRo Capital (NASDAQ:SSSS) with a Outperform and raises the price target from $17 to $18.
05-07 06:49
CORRECTION: SuRo Capital Q1 EPS $(0.16) Misses $(0.14) Estimate, Sales $731.963K Beat $405.500K Estimate
SuRo Capital (NASDAQ:SSSS) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.14) by 14.29 percent. This is unchanged from the same period last year. The company reported
05-06 06:15
SuRo Capital Reports Q1 2026 Results: Full Earnings Call Transcript
SuRo Capital (NASDAQ:SSSS) released first-quarter financial results and hosted ...
05-06 05:59
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
